Skip to main content
Home
FULL MENU Close Menu
Home
Home

Caleb Rans

News

Single-fraction spine stereotactic radiosurgery is cost-efficient

Author:
Caleb Rans
Publish date: December 9, 2019

Investigators quantified institutional costs associated with radiation treatment options for spinal metastases and found single-fraction...

  • Read More

News

SOX11 shows value as diagnostic marker in MCL

Author:
Caleb Rans
Publish date: December 4, 2019

The meta-analysis evaluated the diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma.

  • Read More

News

Glucocorticoids linked to damage accrual in SLE regardless of disease activity

Author:
Caleb Rans
Publish date: December 3, 2019

“These findings suggest that unnecessary use of glucocorticoids should be avoided in the manage­ment of the disease where possible,” study authors...

  • Read More

News

Frontline ibrutinib saves money over chemoimmunotherapy

Author:
Caleb Rans
Publish date: November 20, 2019

An analysis of claims data for more than 1,000 patients with chronic lymphocytic leukemia shows that ibrutinib monotherapy is a less expensive...

  • Read More

News

Early lenalidomide may delay progression of smoldering myeloma

Author:
Caleb Rans
Publish date: November 19, 2019

Researchers said the findings from the phase 3 study support early treatment as the new standard of care in patients with high-risk smoldering...

  • Read More

News

Study detects lower CV risk in breast cancer survivors

Author:
Caleb Rans
Publish date: November 14, 2019

At time of first myocardial infarction, those with a breast cancer history were older, had fewer risk factors, and ultimately had better outcomes...

  • Read More

News

Lorlatinib induces deep responses in ROS1-positive NSCLC

Author:
Caleb Rans
Publish date: November 13, 2019

Among 40 crizotinib-pretreated patients, 14 patients (35%) had an objective response on lorlatinib, with a median duration of response of 13.8...

  • Read More

News

Caspofungin bests fluconazole for antifungal prophylaxis in young AML patients

Author:
Caleb Rans
Publish date: November 5, 2019

The study suggests that caspofungin is a viable option for prophylaxis against invasive fungal disease in children and young adults with acute...

  • Read More

News

Levofloxacin prophylaxis improves survival in newly diagnosed myeloma

Author:
Caleb Rans
Publish date: November 1, 2019

Levofloxacin looks like a promising addition to therapy, but the researchers cautioned that antibiotic resistance must be considered.

  • Read More

News

Adding pertuzumab shows benefit in ERBB2-positive breast cancer

Author:
Caleb Rans
Publish date: October 31, 2019

Total pathologic complete response rates were significantly higher for patients in the pertuzumab arm (39.3%) compared with the placebo arm (21.8...

  • Read More

News

MMS linked with better survival in early-stage melanoma

Author:
Caleb Rans
Publish date: October 28, 2019

Patients who underwent Mohs micrographic surgery had moderately better survival, compared with those who were treated with wide margin excision....

  • Read More

News

SEER analysis reveals medication adherence factors in newly diagnosed myeloma

Author:
Caleb Rans
Publish date: October 24, 2019

The study found that more than a third of older patients with multiple myeloma had poor adherence to lenalidomide.

  • Read More

News

Pembrolizumab shows promise for relapsed/refractory PMBCL

Author:
Caleb Rans
Publish date: October 24, 2019

The findings raise the question of whether PD-1 blockade could resensitize tumors to chemotherapy.

  • Read More

News

Exercise intolerance linked to neurocognitive dysfunction in ALL

Author:
Caleb Rans
Publish date: October 22, 2019

More study is needed to determine whether increasing exercise capacity would improve neurocognitive outcomes for childhood survivors of acute...

  • Read More

News

Ibrutinib linked to hypertension in B-cell malignancies

Author:
Caleb Rans
Publish date: October 15, 2019

New or worsening hypertension was also linked with a greater risk of major adverse cardiac events.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Do Not Sell My Personal Information

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close